Modulation of allergic airways disease employing bio-mimetic nanoparticles with TLR agonists
These findings support the feasibility of nanoparticle-based AIT strategies, while also highlighting the need for further optimization to enhance efficacy, minimize sensitization, and promote sustained long-term immune tolerance.
Authors
- Fabian Blank (ORCID: https://orcid.org/0000-0002-3374-0414)
- Céline Ferrié (ORCID: https://orcid.org/0000-0002-0181-2727)
- Mario Amacker (ORCID: https://orcid.org/0000-0003-2574-4092)
- Melanie Scalise (ORCID: https://orcid.org/0009-0009-8213-0725)
- Seyran Mutlu (ORCID: https://orcid.org/0009-0008-0289-3881)
- Christophe von Garnier (ORCID: https://orcid.org/0000-0003-3585-9176)
- Philip Stumbles
Institutions
- University of Bern (CH)
- The Kids Research Institute Australia (AU)
- Murdoch University (AU)
- Princess Margaret Hospital for Children (AU)
- University Hospital of Bern (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- Perth Children's Hospital
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/falgy.2025.1633293
- Citations
- 2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- University of Bern
- Inselspital, Universitätsspital Bern